Prognosis after recurrence of hepatocellular carcinoma in liver transplantation: predictors for successful treatment and survival
- 14 November 2015
- journal article
- Published by Wiley in Clinical Transplantation
- Vol. 29 (12) , 1156-1163
Abstract
There are no established prognostic factors or standardized therapies for hepatocellular carcinoma (HCC) recurrence in liver transplantation (LT). The aim of this study was to investigate impact of underlying patient condition on treatment and outcomes of recurrence of HCC after LT. The medical records of 268 LT patients with HCC were evaluated. Potential prognostic factors for survival after recurrence were evaluated, including recurrent tumor characteristics, medical/radiological/surgical therapies for recurrence, and an inflammatory marker (neutrophil/lymphocyte ratio). Laboratory tests at recurrence, including albumin, absolute lymphocyte count (ALC), prognostic nutritional index (PNI: ALC(/μL) × 0.005 + Albumin(g/dL) × 10), were evaluated as surrogate markers for underlying patient conditions. A total of 51 (19%) patients developed HCC recurrence. The use of sirolimus and sorafenib significantly improved outcome (p = 0.007 and 0.04), and better nutritional status (PNI ≥ 40) enhanced their efficacy. On multivariate analysis, low ALC (3.5 g/dL], respectively). Low PNI (<40) showed significantly lower survival rate after adjusting the risk (p = 0.006, hazard ratio = 3.29). Underlying patient conditions and nutritional status, represented by ALC and albumin, are important to successful cancer treatment and strong prognostic markers for survival after HCC recurrence.Keywords
This publication has 28 references indexed in Scilit:
- CD4 lymphopenia to identify end-of-life metastatic cancer patientsEuropean Journal of Cancer, 2013
- Meta‐analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinomaAlimentary Pharmacology & Therapeutics, 2012
- Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis patternCritical Care, 2012
- Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unitCritical Care, 2010
- Nutritional predictors of postoperative outcome in pancreatic cancerBritish Journal of Surgery, 2010
- Prognostic nutritional Index: A tool to predict the biological aggressiveness of gastric carcinomaSurgery Today, 2010
- Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteriaLiver Transplantation, 2009
- Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular CarcinomaAnnals of Surgery, 2009
- Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humansHepatology, 2006
- Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact SurvivalHepatology, 2001